Sinopharm Group Co. Ltd Financial Flexibility Index
Sinopharm Group Co. Ltd financial flexibility index. Sinopharm Group Co. Ltd (X2S) has a Financial Flexibility Index of -0.01x as of June 2023. Free cash flow of €-2.32 Billion (operating CF €-2.63 Billion minus capex €312.96 Million) represents 0% of total liabilities (€304.58 Billion). See X2S cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Sinopharm Group Co. Ltd (2013–2025)
Financial flexibility index of Sinopharm Group Co. Ltd from 2013 to 2025. Historical Financial Flexibility Index trend for Sinopharm Group Co. Ltd across 13 annual periods. Check X2S operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Sinopharm Group Co. Ltd Financial Flexibility Index by Year (2013–2025)
Sinopharm Group Co. Ltd financial flexibility index by year from 2013 to 2025. Year-by-year free cash flow to debt coverage for Sinopharm Group Co. Ltd. For the full cash flow conversion analysis, see how efficiently does Sinopharm Group Co. Ltd generate cash.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.06x | €15.76 Billion | €14.14 Billion | €256.20 Billion | ▲ +21.1% |
| 2024 | 0.05x | €13.51 Billion | €11.55 Billion | €266.14 Billion | ▼ -31.5% |
| 2023 | 0.07x | €19.51 Billion | €17.17 Billion | €263.08 Billion | ▼ -18.2% |
| 2022 | 0.09x | €23.09 Billion | €20.96 Billion | €254.71 Billion | ▲ +87.8% |
| 2021 | 0.05x | €11.38 Billion | €9.31 Billion | €235.76 Billion | ▼ -18.1% |
| 2020 | 0.06x | €13.05 Billion | €11.15 Billion | €221.29 Billion | ▼ -45.8% |
| 2019 | 0.11x | €20.98 Billion | €18.78 Billion | €192.95 Billion | ▲ +164.2% |
| 2018 | 0.04x | €6.89 Billion | €3.65 Billion | €167.50 Billion | ▼ -8.7% |
| 2017 | 0.05x | €5.33 Billion | €3.21 Billion | €118.27 Billion | ▼ -52.0% |
| 2016 | 0.09x | €10.62 Billion | €9.26 Billion | €113.18 Billion | ▼ -35.9% |
| 2015 | 0.15x | €14.43 Billion | €13.41 Billion | €98.55 Billion | ▲ +92.9% |
| 2014 | 0.08x | €7.01 Billion | €5.56 Billion | €92.37 Billion | ▼ -3.9% |
| 2013 | 0.08x | €6.07 Billion | €4.94 Billion | €76.84 Billion | — |